Gilder, Gagnon, Howe & Co »

Nektar Therapeutics shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 225k 56.90
2025-06-30 $747k 29k 25.84

More positions owned by Gilder, Gagnon, Howe & Co

Netflix (NFLX)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Cloudflare Cl A Com (NET)
Shopify Cl A Sub Vtg Shs (SHOP)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Roblox Corp Cl A (RBLX)
Intuitive Surgical Com New (ISRG)
Duolingo Cl A Com (DUOL)
Toast Cl A (TOST)
Quanta Services (PWR)
Natera (NTRA)
Alnylam Pharmaceuticals (ALNY)
Tko Group Holdings Cl A (TKO)

View all positions for Gilder, Gagnon, Howe & Co

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics